Related Experiment Video
Updated: May 2, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Updating the OMERACT filter: implications for patient-reported outcomes
John R Kirwan1, Susan J Bartlett, Dorcas E Beaton
1From the University of Bristol, Academic Rheumatology Unit, and the University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, and Department of Medical Humanities, VU University Medical Center, Amsterdam, The Netherlands; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Faculty of Health Sciences, University of Queensland, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Université de Lorraine, Université Paris Descartes, Paris, France; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Amsterdam, The Netherlands; Healthy Motivation, Bone and Joint Decade, Santa Barbara, California, USA; Cochrane Musculoskeletal Group, Institute of Population Health, Ottawa, Ontario, Canada; Department of Rheumatology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia; Consumer Advisory Board, Arthritis Research Centre of Canada, Richmond, British Columbia, Canada; UCB Pharma S.A., Brussels, Belgium; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France.
Patient involvement is crucial for developing reliable patient-reported outcome (PRO) instruments. Current practices align with new OMERACT Filter 2.0 proposals, emphasizing patient partnership and clear communication.
Area of Science:
- Rheumatology
- Patient-Reported Outcomes
- Instrument Development
Background:
- Previous Outcome Measures in Rheumatology (OMERACT) meetings highlighted the need for explicit patient-reported outcome (PRO) instrument development protocols.
- Participants requested enhancements to the OMERACT Filter's
- Truth
- statement for improved outcome validation.
Framework:
- The OMERACT Filter 2.0 proposals aim to provide a more explicit framework for PRO instrument development.
- Key aspects include iterative development and direct patient involvement throughout the process.
Implementation:
- This session evaluated the practicability and feasibility of the proposed Filter 2.0 framework.
- Case studies from OMERACT Working Groups were reviewed to assess current compliance and identify areas for improvement.
- Emphasis was placed on ensuring conceptual clarity and cross-cultural validity in PRO instruments.
Implications:
- Participants recognized and endorsed the proposed principles, with many already implementing them.
- Further work is needed to refine existing instruments and promote widespread adoption of collaborative patient engagement.
- This initiative seeks to enhance the rigor and reliability of PRO instruments in rheumatology research.
More Related Videos
12:20Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
Related Concept Videos
Methods of Documentation II: POMR
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials: Overview
Therapeutic Drug Monitoring: Affecting Factors
Clinical Trials
There are four phases in a clinical trial. A phase one...